0001214659-23-012446.txt : 20230919 0001214659-23-012446.hdr.sgml : 20230919 20230919092410 ACCESSION NUMBER: 0001214659-23-012446 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230905 FILED AS OF DATE: 20230919 DATE AS OF CHANGE: 20230919 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Krogulski Kenneth CENTRAL INDEX KEY: 0001695580 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-33637 FILM NUMBER: 231262644 MAIL ADDRESS: STREET 1: 2525 WEST END AVENUE, SUITE 950 CITY: NASHVILLE STATE: TN ZIP: 37203 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CUMBERLAND PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001087294 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2525 WEST END AVENUE STREET 2: SUITE 950 CITY: NASHVILLE, STATE: TN ZIP: 37203 BUSINESS PHONE: 615-255-0068 MAIL ADDRESS: STREET 1: 2525 WEST END AVENUE STREET 2: SUITE 950 CITY: NASHVILLE STATE: TN ZIP: 37203 4 1 marketforms-62634.xml PRIMARY DOCUMENT X0508 4 2023-09-05 0001087294 CUMBERLAND PHARMACEUTICALS INC CPIX 0001695580 Krogulski Kenneth 1600 WEST END AVE., SUITE 1300 NASHVILLE TN 37203 true false false false 1 Common Stock 2023-09-05 5 L false E 325 1.71 A 214019 D Common Stock 2023-09-06 5 L false E 325 1.68 A 214344 D Common Stock 2023-09-07 5 L false E 325 1.71 A 214669 D Common Stock 2023-09-08 5 L false E 325 1.71 A 214994 D Common Stock 2023-09-11 5 L false E 325 1.74 A 215319 D Common Stock 2023-09-12 5 L false E 325 1.79 A 215644 D Common Stock 2023-09-13 5 L false E 325 1.86 A 215969 D Common Stock 2023-09-14 5 L false E 325 1.87 A 216294 D Common Stock 2023-09-15 5 L false E 72 1.82 A 216366 D The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May16, 2023. Kenneth J. Krogulski by /s/ John Hamm as attorney-in-fact 2023-09-19